[ad_1]
In the fight against the corona virus, which infects more than 28 million people worldwide and killed more than 900,000 people, many countries, institutions and companies have entered a fierce struggle to produce medicines and vaccines. ..
While many companies made great strides in the final phase, the vaccination process developed by AstraZeneca and the University of Oxford earlier this week was suspended due to “side effects.” The details of this event, which is on the agenda of international public opinion, appeared days later.
“VERY SERIOUS SYMPTOMS ARE SHOWN”
The US media wrote that Pascal Soriot, CEO of AstraZeneca, made a statement to investors and shareholders. Speaking to shareholders, Soriot explained that a woman who voluntarily tested the vaccine in the UK showed “very severe neurological symptoms” during the trial.
Claiming that a previously undetected neurological disorder occurred, Soriot said they decided to stop the trials on a global scale.
A VOLUNTEER WAS MS
In news from Statnews.com, which makes US-based health and medical news, it was revealed that AstraZeneca and the University of Oxford also found a neurological case in July. However, it was noted that the case in that case turned into multiple sclerosis (MS) and the reason for this was not vaccination.
Soriot did not give a clear date on when the vaccine will be ready, but said: “A vaccine that nobody wants to use is not very beneficial.”
RELATED NEWS
[ad_2]
